Literature DB >> 16311924

Molecular cloning and expression of novel alternatively spliced cytochrome P450 2E1 mRNAs in humans.

Mario Bauer1, Olf Herbarth, Gabi Aust, Carolin Graebsch.   

Abstract

Human cytochrome P450 2E1 (CYP2E1) is a phase I metabolizing enzyme. It is involved in the biotransformation of xenobiotics and endogenous substrates. Inter-individual genetic polymorphisms of the CYP2E1 gene are associated with different cancer diseases as well as alcohol and nicotine dependence. We report here for the first time three novel alternative spliced mRNA transcripts which are more frequently present in lung carcinoma cell lines as in hepatocyte cell lines. They are unexpected detectable in blood leukocytes from healthy volunteers but not in normal and cancerous lung tissue. The full-length wildtype transcript of CYP2E1 is described to be concomitant to an alternatively spliced mRNA transcript. Stimulation with CYP2E1-inducing agents did not change the splicing transcript pattern. The three splicing variants should lead to truncated non-functional proteins. Thus the genetic diversity of CYP2E1 is additionally extended at the transcriptional level of gene expression. The physiological role of the splicing variants is not known, yet, but they seem to be related to the carcinogenic property of the cell lines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311924     DOI: 10.1007/s11010-005-0169-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

1.  Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population.

Authors:  M Murata; M Watanabe; M Yamanaka; Y Kubota; H Ito; M Nagao; T Katoh; T Kamataki; J Kawamura; R Yatani; T Shiraishi
Journal:  Cancer Lett       Date:  2001-04-26       Impact factor: 8.679

Review 2.  Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation.

Authors:  C S Yang; J S Yoo; H Ishizaki; J Y Hong
Journal:  Drug Metab Rev       Date:  1990       Impact factor: 4.518

3.  Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk.

Authors:  Loïc Le Marchand; Timothy Donlon; Ann Seifried; Lynne R Wilkens
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-10       Impact factor: 4.254

4.  Polymorphism of CYP450 and cancer susceptibility.

Authors:  X M Han; H H Zhou
Journal:  Acta Pharmacol Sin       Date:  2000-08       Impact factor: 6.150

5.  Interindividual variance of cytochrome P450 forms in human hepatic microsomes: correlation of individual forms with xenobiotic metabolism and implications in risk assessment.

Authors:  J E Snawder; J C Lipscomb
Journal:  Regul Toxicol Pharmacol       Date:  2000-10       Impact factor: 3.271

Review 6.  Alcohol-inducible cytochrome P-450 (P-450ALC).

Authors:  M J Coon; D R Koop
Journal:  Arch Toxicol       Date:  1987       Impact factor: 5.153

7.  Stabilization of cytochrome P450j messenger ribonucleic acid in the diabetic rat.

Authors:  B J Song; T Matsunaga; J P Hardwick; S S Park; R L Veech; C S Yang; H V Gelboin; F J Gonzalez
Journal:  Mol Endocrinol       Date:  1987-08

8.  Regulation of rabbit cytochrome P450 2E1 expression in HepG2 cells by insulin and thyroid hormone.

Authors:  H M Peng; M J Coon
Journal:  Mol Pharmacol       Date:  1998-10       Impact factor: 4.436

9.  Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese.

Authors:  E A Stephens; J A Taylor; N Kaplan; C H Yang; L L Hsieh; G W Lucier; D A Bell
Journal:  Pharmacogenetics       Date:  1994-08

10.  Tandem repeat polymorphism of the CYP2E1 gene: an association study with esophageal cancer and lung cancer.

Authors:  Sakae Itoga; Fumio Nomura; Yasuhiko Makino; Takeshi Tomonaga; Hideaki Shimada; Takenori Ochiai; Toshihiko Iizasa; Masayuki Baba; Takehiko Fujisawa; Shoji Harada
Journal:  Alcohol Clin Exp Res       Date:  2002-08       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.